All Posts

Genetic score shows promise in improving leukemia outcomes

By allowing chemotherapy regimens to be personalized, a genetic score holds promise for improving treatment results in patients with acute myeloid leukemia (AML) who have traditionally had poor outcomes, UF Health researchers have found.

Research Snapshot: Researchers identify genes that predict pediatric AML outcomes

UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.